why choose us

First received: October 27, 2023

Clinical Trial: Efficacy of Glucagon-like Peptide-1 Receptor Agonists According to Type 2 Diabetes Subtypes

Study Status: Completed

Recruit Status: RECRUITING

Condition: Diabetes Mellitus, Type 2

Study Type: OBSERVATIONAL


Official Title: Efficacy of Glucagon-like Peptide-1 Receptor Agonists According to Type 2 Diabetes Subtypes: an Italian Monocentric Retrospective Study

Brief Summary: The goal of this observational retrospective study is to understand whether glucagon-like peptide-1 receptor agonists (GLP-1RA), which are a group of antidiabetes drugs, may act differently in different subtypes of patients with type 2 diabetes.The main questions it aims to answer are:people with type 2 diabetes belonging to specific subtypes respond better (or worse) to GLP-1RA?the beneficial effect of GLP-1RA may last longer in people with type 2 diabetes belonging to specific subtypes?what are the clinical…

Read more